News

Urinary incontinence affects millions of older Americans but is likely underreported, according to the 2024 Urologic Diseases in America: Annual Data Report.

Margot Damaser has long been fascinated by bladders, urine and figuring out what’s wrong when a person can’t tinkle properly.

According to Howard B. Goldman, MD, the idea for the device came from an understanding of the limitations of traditional urodynamics.

Cleveland Clinic is the first to use the Glean™ Urodynamics System, the first wireless, catheter-free method of urodynamic monitoring following 510(k) clearance from the U.S. Food and Drug Administration in March.

Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced that its recent feasibility study was published in the Journal of Endourology. Results showed that the Glean™ Urodynamics System is a safe, and well-tolerated device that enables ambulatory urodynamics without catheters impeding lower urinary tract function.

IRVINE, Calif.--(BUSINESS WIRE)--Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Glean™ Urodynamics System, a comprehensive system that enables wireless, catheter-free ambulatory urodynamics designed to support clinical decision making for patients with LUTD and other urologic

The system overcomes current catheter-based urethral pressure testing, which is uncomfortable and often generates imprecise data. Bright Uro, a company transforming care for lower urinary tract dysfunction (LUTD) through urodynamics innovations, has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its Glean urodynamics system. Urodynamics is the science of testing how well the bladder, sphincters, and urethra hold and release urine to determine the so

Glean, a comprehensive system, enables wireless, catheter-free urodynamics. Bright Uro aims to provide clinicians with more accurate data and actionable insights to aid in clinical decision-making. Glean features an insertion tool and a Bluetooth-enabled pressure sensor in a flexible silicone tube. It also has a software app for use by clinicians and patients and a uroflowmeter to sense volume and flow.

Bright Uro Announces Award from Congressional Spinal Cord Injury Research Program IRVINE, Calif., Jan. 7, 2025 /PRNewswire/ — Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms through innovations in urodynamics, today announced a Translational Research Award of $1.75 million from the Spinal Cord Injury Research Program (SCIRP), a Department of Defense Congressionally Directed Medical Research Program1, to support new produ

Dec 2019 – ‘A Fitbit for the Bladder’: UroMonitor Takes Monitoring Out of the Clinic Clinical trials for a urinary incontinence device are scheduled to begin soon.

Bright Uro Snags $23M To Make Urology Diagnostics Easier for Providers & Patients Bright Uro raised $23 million in Series A funds to help achieve FDA clearance for its urodynamics system and launch the product in the U.S. Should it be cleared, the system will become the first product on the market able perform urodynamic monitoring wirelessly and without a catheter, the company’s CEO said…

Bright Uro raises $23M to transform care for lower urinary tract symtoms Lower urinary tract symptoms (LUTS) affect up to 70% of adult men and women, a population comprised of people dealing with conditions such as overactive bladder, urinary incontinence, and benign prostate hyperplasia. Depending on the specific condition, treatments may include surgeries, medications, such as α-blockers or anticholinergics, or some combination of the two…

Bright Uro shines with $23M series A for Glean urodyanmics system Bright Uro Inc. raised $23 million in a series A fundraising round to support its pursuit of U.S. FDA 510(k) clearance and launch of its Glean urodynamics system. Glean offers catheter-less assessment of the function of the bladder and urethra that uses an inserted pressure sensor instead…

Bright Uro pockets $23 million to advance urodynamics system Bright Uro announced Thursday that it has raised $23 million in a Series A financing round led by Laborie Medical Technologies. Bright Uro, which said it aims to transform care for lower urinary tract symptoms, plans to use the proceeds to gain FDA 510(k) clearance for its Glean urodynamics system and launch the product in the US next year...

Bright Uro Announces $23M Series A Funding Round Led by Laborie – Expands Senior Leadership Team to Accelerate Next Phase of Commercialization IRVINE, Calif.–(BUSINESS WIRE)–Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, today announced the initial closing of its $23M Series A financing round led by Laborie Medical Technologies, a leading global provider of urology diagnostic a

Bright Uro raises $23M Series A to Support urodynamics system Bright Uro announced today that it closed $23 million in a Series A funding round to support its Glean urodynamics system. Irvine, California-based Bright Uro plans to use the funding to help garner FDA 510(k) clearance for Glean. It set its sights on a U.S. launch for the product in 2024…

Changing the Standard of Care for Urology Patients DocWire News recently spoke with Derek Herrera, Founder and CEO of Bright Uro, a seed stage medical device company focused on developing the next generation of diagnostic devices for urology…

Bright Uro Announces Oversubscribed $32M Series A Funding Round Bright Uro a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, today announced the second closing of its Series A funding round, which was oversubscribed by nearly 40% above and secured a total of $32M for the company…

Bright Uro adds two industry pioneers to its Board od Directors Martha Goldberg Aronson and Dr. Sanford Siegel to provide leadership and guidance for upcoming product launch IRVINE, Calif., Oct. 17, 2024 /PRNewswire/ — Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in…

Bright Uro adds two industry pioneers to its Board od Directors Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, today announced the addition of two industry pioneers to its Board of Directors. Martha Goldberg Aronson, a 25-year industry veteran, joins the board as a Director, and Sanford Siegel, MD brings decades of urology and practice leadership experience to his new role as B